Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action (Q40418236)

20 September 2017

1 reference

title

Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action (English)

1 reference

20 September 2017

0 references

1 reference

Keaney JF Jr

1

1 reference

20 September 2017

Vita JA

series ordinal

2

1 reference

20 September 2017

publication date

1 September 1995

1 reference

Progress in Cardiovascular Diseases

20 September 2017

published in

1 reference

20 September 2017

volume

38

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

129-154

1 reference

Localization of nitric oxide synthase indicating a neural role for nitric oxide

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Biochemistry of Nitric Oxide and Its Redox-Activated Forms

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Oxygen-mediated heterogeneity of apo-low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Enhanced macrophage degradation of biologically modified low density lipoprotein.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Role of endothelial cells and their products in the modification of low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Superoxide initiates oxidation of low density lipoprotein by human monocytes

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

beta-Carotene inhibits the oxidative modification of low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Atherosclerosis in cholesterol-fed Japanese quail: evidence for amelioration by dietary vitamin E

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted ovulator chickens

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The effect of chronic hypovitaminosis C on the metabolism of cholesterol and atherogenisis in guinea pigs

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Dietary ascorbic acid depresses plasma and low density lipoprotein lipid peroxidation in genetically scorbutic rats

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Probucol inhibits oxidative modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Influence of probucol on early experimental atherogenesis in hypercholesterolemic rats

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Estrogens inhibit copper and cell-mediated modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The inhibition of low-density lipoprotein oxidation by 17-beta estradiol

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Vitamin E consumption and the risk of coronary disease in women

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Long-time treatment of intermittent claudication with vitamin E.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Angiographic morphology and the pathogenesis of unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Angiographic assessment of the culprit coronary artery lesion before acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Relation between coronary artery stenosis assessed by visual, caliper, and computer methods and exercise capacity in patients with single-vessel coronary artery disease. The Veterans Affairs ACME Investigators

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Role of endothelium in responses of vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Hypercholesterolemia increases endothelial superoxide anion production

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Inactivation of alpha 1-proteinase inhibitor by peroxynitrite

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Pathological implications of nitric oxide, superoxide and peroxynitrite formation

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The reaction of no with superoxide

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Physiological release of nitric oxide is dependent on the level of vascular tone

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Hypertension in the Wistar-Kyoto rat as a result of post-weaning copper restriction

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Alterations in human vascular endothelial cell function by oxygen free radicals. Platelet adherence and prostacyclin release

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Dipyridamole inhibits platelet aggregation induced by oxygen-derived free radicals

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Superoxide anions enhance platelet adhesion and aggregation

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Direct electrochemical measurement of nitric oxide released from human platelets

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Involvement of nitric oxide in the endothelium‐dependent relaxation induced by hydrogen peroxide in the rabbit aorta

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Ca2 /calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

H2O2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The reaction of nitric oxide with organic peroxyl radicals

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

FAD and GSH participate in macrophage synthesis of nitric oxide

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Inactivation of endothelial derived relaxing factor by oxidized lipoproteins

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Regulation of guanylate and adenylate cyclase activities by lysolecithin

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Parallel modulation of catecholamine activation of adenylate cyclase and formation of the high-affinity agonist.receptor complex in turkey erythrocyte membranes by temperature and cis-vaccenic acid

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Evidence that lysolecithin is an important causal agent of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Hypercholesterolemia promotes endothelial dysfunction in vitamin E- and selenium-deficient rats

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Effect of low-dose probucol therapy on LDL oxidation and the plasma lipoprotein profile in male volunteers

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Antioxidant activities of probucol against lipid peroxidations

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Preservation of Endothelium-Dependent Relaxation in Atherosclerotic Rabbit Aorta by Probucol

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Macrophage foam cells from human aortic fatty streaks take up beta-VLDL and acetylated LDL in primary culture

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Estrogens as natural antioxidants of membrane phospholipid peroxidation

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Ascorbate is an outstanding antioxidant in human blood plasma

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Increased preferential absorption in human atherosclerotic plaque with oral beta carotene. Implications for laser endarterectomy.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Oxidatively modified human low-density lipoprotein stimulates leukocyte adherence to the microvascular endothelium in vivo

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937.

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Biologically modified LDL increases the adhesive properties of endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occu

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Protective role of intracellular glutathione against oxidized low density lipoprotein in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Toxicity of oxidised low density lipoprotein towards mouse peritoneal macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Vitamin E inhibits protein kinase c activity

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans

1 reference

https://api.crossref.org/works/10.1016/S0033-0620(05)80003-9

7 January 2021

10.1016/S0033-0620(05)80003-9

Identifiers

DOI

1 reference

20 September 2017

1 reference